Literature DB >> 12910825

[Depressive symptoms following ischemic stroke].

Lidia Głodzik-Sobańska1, Agnieszka Słowik, Anna Borratyńska, Andrzej Szczudlik.   

Abstract

Depressed mood and other depressive symptoms frequently seen after cerebral stroke contribute to an unfavorable prognosis in this patient population. Identification of the subgroup of patients at increased risk for depressive symptoms is a prerequisite of early treatment. In the study aimed at evaluation of post-stroke depressive symptoms prevalence and risk factors participants were 766 consecutive patients with ischemic cerebral infarction, admitted in the years 1997-2000 to the Stroke Unit, Neurology Department in Cracow. Data concerning depressive symptoms, demographic characteristics and clinical variables were obtained from medical records. Depressive symptoms during the hospitalization were found in 19% of cases. Younger age, neurological deficits and previous history of psychiatric disorders were independent factors increasing the risk of post-stroke depressive symptoms. The study allowed to identify the subpopulation of stroke patients at risk for affective disorders following a cerebrovascular accident.

Entities:  

Mesh:

Year:  2003        PMID: 12910825

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  2 in total

1.  Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.

Authors:  Jing Jin; Qi Peng; Zhipeng Hou; Mali Jiang; Xin Wang; Abraham J Langseth; Michael Tao; Peter B Barker; Susumu Mori; Dwight E Bergles; Christopher A Ross; Peter J Detloff; Jiangyang Zhang; Wenzhen Duan
Journal:  Hum Mol Genet       Date:  2015-01-21       Impact factor: 6.150

2.  Post-stroke depression: prevalence and relationship with disability in chronic stroke survivors.

Authors:  Abhishek Srivastava; Arun B Taly; Anupam Gupta; Thyloth Murali
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.